WADE JEFFREY L 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Jul 8, 2024
Insider Transaction Report
Form 4
WADE JEFFREY L
EVP, Gen. Counsel
Transactions
- Award
Stock Option (Right to Buy)
2024-07-08+307,000→ 307,000 totalExercise: $1.67Exp: 2034-07-08→ Common Stock (307,000 underlying)
Footnotes (1)
- [F1]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.